Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Capital Markets Modernization Taskforce: Final Report 2021

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Feb 17, 2021 1:22pm

155 Views

Post# 32585911

RE:RE:RE:RE:RE:Capital Markets Modernization Taskforce: Final Report 2021

Perhaps I've drank too much koolaid but I think its takes a lot of effort to keep a stock like TLT with so much going on and its potential down where it is. Even at a buck a share, that barely gives us credit for Friday's announcement of U of M Covid research IMO. Not enough volume to prevent the penny flippers from sucking the wind out of the sails. Shouldn't have been so easy to sell it down yesterday after Fridays run.

<< Previous

Bullboard Posts

Next >>

NervGen: Are amazing human trial results leaking out?